Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma

Phase 1

Active, not recruiting

Conditions: Malignant Pleural Mesothelioma

Interventions: Drug: Nivolumab
Drug: Pemetrexed
Drug: Cisplatin or Carboplatin

First Posted Date: 2019-11-13

Last Posted Date: 2024-06-25

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT04162015

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 4 locations

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Completed

Conditions: Esophagogastric Cancer
Esophageal Cancer
Gastric Adenocarcinoma
Esophagus Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction Squamous Cell Carcinoma

Interventions: Drug: IV 18F-BMS-986229
Drug: 18F-BMS-986229 Injection
Diagnostic Test: PET/CT Scan

First Posted Date: 2019-11-13

Last Posted Date: 2024-03-08

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT04161781

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery

Phase 1

Active, not recruiting

Conditions: Pancreatic Cancer

Interventions: Drug: Atezolizumab
Biological: RO7198457
Drug: mFOLFIRINOX

First Posted Date: 2019-11-13

Last Posted Date: 2025-01-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 29

Registration Number: NCT04161755

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center @ Commack (All Protocol Activities), Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States

and more 4 locations

A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy

Phase 2

Active, not recruiting

Conditions: B Cell ALL
B-Cell Lymphoma
B-cell Non Hodgkin Lymphoma

Interventions: Drug: Anakinra

First Posted Date: 2019-11-01

Last Posted Date: 2024-11-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 62

Registration Number: NCT04148430

Locations: 🇺🇸
Hackensack Meridian Health (Data collection only), Hackensack, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Phase 2

Recruiting

Conditions: Liver Metastases

Interventions: Diagnostic Test: [18-F]- FDG - PET
Procedure: Tumor ablation (TA)
Diagnostic Test: PET/CT Scan

First Posted Date: 2019-10-29

Last Posted Date: 2024-08-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 200

Registration Number: NCT04143516

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Armed, Activated T-Cells in Patients With Advanced Pancreatic Cancer

Phase 1

Active, not recruiting

Conditions: Advanced Pancreatic Cancer
Pancreatic Neoplasms
Pancreatic Adenocarcinoma
Pancreatic Cancer

Interventions: Drug: anti-EGFR-bispecific antibody armed activated T-cells

First Posted Date: 2019-10-24

Last Posted Date: 2024-05-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT04137536

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
University of Virginia (Specimen Analysis), Charlottesville, Virginia, United States

Supportive Care Delivered by Telemedicine to Cancer Patients at Home

Not Applicable

Active, not recruiting

Conditions: Supportive Care
Cancer

Interventions: Other: In-person in clinic follow-up visit
Other: Telemedicine follow-up visit

First Posted Date: 2019-10-23

Last Posted Date: 2024-11-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 33

Registration Number: NCT04136340

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Phase 2

Active, not recruiting

Conditions: Endometrial Carcinosarcoma
Endometrial Adenocarcinoma

Interventions: Drug: Nivolumab
Drug: BMS- 986205

First Posted Date: 2019-09-27

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT04106414

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

Looking at Cognitive and Brain Changes in People With Lymphoma Receiving CAR-T Therapy

Recruiting

Conditions: Lymphoma Receiving CAR-T Therapy

Interventions: Behavioral: neurocognitive evaluations
Diagnostic Test: brain MRIs
Other: Blood samples

First Posted Date: 2019-09-27

Last Posted Date: 2024-11-18

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 120

Registration Number: NCT04107285

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of the Experience of Music Therapy in Cancer Patients With Delirium

Completed

Conditions: Cancer Patients With Delirium

Interventions: Behavioral: Music therapy
Behavioral: Interviews

First Posted Date: 2019-09-26

Last Posted Date: 2023-08-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 17

Registration Number: NCT04104217

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy